KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 108 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,616,305 | -29.8% | 243,151 | -2.3% | 0.00% | 0.0% |
Q4 2022 | $3,729,465 | +8.4% | 248,963 | -7.0% | 0.00% | 0.0% |
Q3 2022 | $3,439,000 | +27.9% | 267,766 | -3.5% | 0.00% | 0.0% |
Q2 2022 | $2,688,000 | -2.5% | 277,384 | 0.0% | 0.00% | – |
Q1 2022 | $2,757,000 | -22.1% | 277,384 | -7.7% | 0.00% | -100.0% |
Q4 2021 | $3,538,000 | -23.0% | 300,641 | -25.4% | 0.00% | 0.0% |
Q3 2021 | $4,592,000 | -18.2% | 403,200 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $5,617,000 | +203.1% | 403,200 | +302.8% | 0.00% | – |
Q1 2021 | $1,853,000 | +4.7% | 100,100 | 0.0% | 0.00% | – |
Q4 2020 | $1,769,000 | +44.2% | 100,100 | +25.0% | 0.00% | – |
Q3 2020 | $1,227,000 | +109.7% | 80,100 | +137.6% | 0.00% | – |
Q2 2018 | $585,000 | – | 33,719 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spearhead Capital Advisors, LLC | 202,580 | $2,601,000 | 2.82% |
Lion Point Capital, LP | 480,000 | $5,140,000 | 1.13% |
HHLR ADVISORS, LTD. | 2,920,023 | $37,493,000 | 0.99% |
TANG CAPITAL MANAGEMENT LLC | 600,000 | $7,704,000 | 0.94% |
Rubric Capital Management LP | 1,446,107 | $18,568,000 | 0.94% |
AlphaCentric Advisors LLC | 43,000 | $552,000 | 0.57% |
RICE HALL JAMES & ASSOCIATES, LLC | 749,933 | $9,629,000 | 0.56% |
Parkman Healthcare Partners LLC | 126,192 | $1,620,000 | 0.46% |
Birchview Capital, LP | 30,000 | $385,000 | 0.27% |
Baker Brothers Advisors | 2,799,577 | $35,947,000 | 0.24% |